2021 Global Conference Coverage: An Update on the Clinical Development Across Gynecologic Malignancies*

Download All
The 2021 SGO Virtual Annual Meeting, 19-25 March 2021, in Seattle, Washington, USA; The 2021 ASCO Annual Meeting, 4-8 June 2021, in Chicago, Illinois, USA; The 2021 IGCS Meeting, 30 August - 2 September, in Rome, Italy; The ESMO 2021 Annual Congress, 17-21 September 2021, in Paris, France; The 2021 ESGO Conference, 23-26 October 2021, in Prague, Czech Republic

Read or listen to 5 expert commentaries providing global perspectives on emerging data in ovarian and endometrial cancers presented at the 2021 meetings of SGO, ASCO, IGCS, ESMO, and ESGO, and then download the slideset with all the key data.

This educational program is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD
Bernard Doger de Spéville, MD, PhD
Melissa M. Hardesty, MD, MPH
person default
Alexandra Leary, MD, PhD
Domenica Lorusso, MD, PhD
Ursula Matulonis, MD
David Scott Miller, MD, FACOG, FACS
Prof Isabelle Ray-Coquard, MD, PhD

ClinicalThought

How do you currently address management challenges in patients with endometrial and ovarian cancers? Read our thoughts on how we currently approach challenges with novel therapies for the treatment of endometrial and ovarian cancers.

This ClinicalThought is intended for clinicians practicing medicine outside of the United States.

Jubilee Brown, MD Ursula Matulonis, MD Released: May 3, 2021

Gynecologic oncology experts share their thoughts on notable new data presented at the 2021 ASCO annual meeting for the treatment of endometrial, ovarian, and cervical cancers.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Melissa M. Hardesty, MD, MPH David Scott Miller, MD, FACOG, FACS Released: July 8, 2021

Gynecologic oncology experts share their takeaways from new clinical data presented at the 2021 IGCS annual meeting for the treatment of endometrial, ovarian, and cervical cancers.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD Released: September 30, 2021

Read this commentary from Prof Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, on the current status and application of actionable biomarkers for ovarian and endometrial cancers in Europe.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Bernard Doger de Spéville, MD, PhD Prof Isabelle Ray-Coquard, MD, PhD Released: October 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue